Enfusion (NYSE:ENFN – Get Rating) and Semrush (NASDAQ:SEMR – Get Rating) are both small-cap IT and technology companies, but which is the best investment? We will compare the two companies based on their risk strength, analyst recommendations, profitability, institutional ownership, valuation, earnings and dividends.
Benefits and evaluation
This table compares the revenue, earnings per share and valuation of Enfusion and Semrush.
|Gross revenue||Price/sales ratio||Net revenue||Earnings per share||Price/earnings ratio|
|In fusion||$111.70 million||11:38||-$158.32 million||N / A||N / A|
|Semrush||$188.00 million||9.78||-3.29 million dollars||($0.05)||-260.80|
Semrush has higher revenue and profit than Enfusion.
This table compares the net margins, return on equity and return on assets of Enfusion and Semrush.
|Net margins||Return on equity||return on assets|
|In fusion||N / A||N / A||N / A|
Insider and Institutional Ownership
61.2% of Enfusion shares are held by institutional investors. Comparatively, 15.1% of Semrush shares are held by institutional investors. 61.9% of Semrush shares are held by insiders. Strong institutional ownership indicates that hedge funds, endowments, and large fund managers believe a company is poised for long-term growth.
This is a breakdown of recent ratings and price targets for Enfusion and Semrush, as provided by MarketBeat.com.
|Sales Ratings||Hold odds||Buy reviews||Strong buy odds||Rating|
Enfusion currently has a consensus target price of $17.00, indicating a potential upside of 51.25%. Semrush has a consensus target price of $16.83, indicating a potential upside of 29.09%. Given Enfusion’s stronger consensus rating and higher possible upside, research analysts clearly believe that Enfusion is more favorable than Semrush.
Enfusion beats Semrush on 8 of the 11 factors compared between the two stocks.
About Enfusion (Get an evaluation)
Enfusion, Inc. provides software-as-a-service solutions for the investment management industry in the United States, Europe, the Middle East, Africa and Asia-Pacific. It provides a portfolio management system, which generates a real-time investment ledger consisting of valuation and risk tools that allow users to analyze aggregated or broken down portfolio data for Chief Investment Officers (CIO ) and portfolio managers; and an order and execution management system that enables portfolio managers, traders, compliance teams and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders and consistently apply business regulations and internal guidelines. The company also offers a general ledger/accounting system, a real-time accounting ledger for CFOs, COOs, accountants, and operations teams; The Enfusion Analytics System, which enables CIOs, portfolio managers, traders and analysts to analyze portfolios across time horizons and automate custom visualized reports for internal and external stakeholders; and services managed and powered by technology. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
About Semrush (Get an evaluation)
Semrush Holdings, Inc. develops software platform as a service for managing online visibility worldwide. The company enables businesses to identify and reach the right audience for their content through the right channels. Its platform enables the company’s clients to understand trends and act on the information to improve online visibility and drive traffic to their websites and social media pages, as well as online listings. , distribute targeted content to their customers, and measure digital marketing campaigns. The company was founded in 2008 and is based in Boston, Massachusetts.
Get news and reviews for Enfusion Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Enfusion and related companies with MarketBeat.com’s free daily email newsletter.